Call us for any question
+91 2227467778Navi Mumbai - 400703
MumbaiOffice Hour: 09:00am - 05:00pm
info@essphar.comIntellectual Property Evaluation (IP related issues & Final IP clearance for drug substances (from attorney).
essphar focuses on developing and manufacturing niche generic formulations, and a leading provider of affordable.
As you might be aware of a couple of European Systems for obtaining the marketing authorization of medicines in Europe.
Qualified experts in Chemistry, Manufacturing & Controls (CMC) comprises scientists with the in-depth experience
Qualified Person for Pharmacovigilance (QPPV) / Pharmacovigilance Officer In-charge (PvOI).
Demand Planning & Forecasting as per the pre-determined target.
We provide the best facilities to the customer, we select a manufacturing unit based on capacity, output and approved by MOH of the respective countries.
Our In-House expert with in-depth experience about the understanding of the molecule and technical input facilitates
Clinical Study Reports, Investigator Brochures, Medical and Scientific Literature Reviews
We provide new opportunities and growth potential to our partners by providing the right partnership model to expand the business.
An optimized portfolio strategy (Portfolio Evaluation by selecting the drug candidate, Prioritization and Optimization) and appropriat.
A globally integrated healthcare organization and recognized worldwide through Innovation, Quality and Competence by assuring high-quality standards and cost-effective pharmaceutical products at all times.
Essphar is a multi-disciplinary firm that are specializing in the Pharmaceutical product development, Analytical Support like method development & method validation, Regulatory Affairs & licensing partner, Pharmacovigilance, Pharmaceuticals Supply, Contract manufacturing, Clinical & Bioequivalence Studies management, Clinical data management, Medical writing and marketing of pharmaceutical and allied products.
read moreWhile our team brings important experience and knowledge, we know that each patient is the expert in their own life
We offer a comprehensive service of new product development and generic product development, focusing on the latest cost-effective manufacturing technologies and RA services.
We serve all the pharmaceutical services from initial development to the pharmaceuticals supply in one place. Where the challenges arise, the team is quick to suggest a solution to it and way of alternatives. Our project managers are available for emails/calls as often as needed and the expertise, knowledge and skill level when required.
Encapsulates skills, implementing innovations to benefit the industry and quest to learn new developments & work in a challenging environment that enables me to be a part of the latest developments in the Pharmaceutical industry.
Intellectual Property Evaluation (IP related issues & Final IP clearance for drug substances (from attorney).
read moreEssphar focuses on developing and manufacturing niche generic formulations, and a leading provider of affordable.
read moreAs you might be aware of a couple of European Systems for obtaining the marketing authorization of medicines in Europe.
read moreQualified experts in Chemistry, Manufacturing & Controls (CMC) comprises scientists with the in-depth experience
read moreQualified Person for Pharmacovigilance (QPPV) / Pharmacovigilance Officer In-charge (PvOI).
read moreDemand Planning & Forecasting as per the pre-determined target.
read moreWe provide the best facilities to the customer, we select a manufacturing unit based on capacity, output and approved by MOH of the respective countries.
read moreOur In-House expert with in-depth experience about the understanding of the molecule and technical input facilitates
read moreClinical Study Reports, Investigator Brochures, Medical and Scientific Literature Reviews
read moreWe provide new opportunities and growth potential to our partners by providing the right partnership model to expand the business.
read moreAn optimized portfolio strategy (Portfolio Evaluation by selecting the drug candidate, Prioritization and Optimization) and appropriat.
read more